Samaritan Partners 'Forgetful' Rat Model to Taconic to Commercialize
The rat model is now available exclusively through Taconic. Samaritanwill receive royalties on net sales. Financial terms were not disclosed.
"Taconic is extremely pleased to offer researchers a new and potentiallyinvaluable weapon in the war on neurodegenerative disease," said Todd Little,President of Taconic. "The rapid time to disease state of the SamaritanAlzheimer's Rat Model will enable investigators to conduct Alzheimer's drugtarget screening on a much faster timeline than ever before."
The rat model is published in Pharmacology, 2006;76:19-33
"Taconic provides us with an experienced partner to monetize this uniqueanimal model to 'rat out' Alzheimer's. The rat model is groundbreaking, inthat it offers significant advantages over other options previously availablefor the study of Alzheimer's. We anticipate Taconic achieving and surpassingprojected market penetrations in international markets," said Dr. Greeson,CEO, Samaritan Pharmaceuticals.
Samaritan's Phase I, Alzheimer's drug Caprospinol (SP-233), utilized "TheSamaritan Alzheimer's Rat Model." and the Morris Water Maze, in an INDenabling, proof of concept study. Treated rats demonstrated Caprospinol'sefficacy by,
Samaritan Pharmaceuticals: "Transforming Today's Science Into Tomorrow'sCures."
Samaritan Pharmaceuticals is a biopharmaceutical company committed tobringing innovative life-saving drugs to suffering patients. Samaritanwebsite: http://www.samaritanpharma.com. Please register for upcomingconference calls, news, and events.
Taconic Farms, Inc.
Taconic was founded in 1952 as a family-owned business in New York's Hudson River Valley. Since then, the company has become one of the largestlaboratory rodent providers in the world with a reputation for consistentlyproducing high quality, well-defined rats and mice. Taconic has six breedingfacilities and three service laboratories in the USA and Europe, a staff ofover 900, and a commitment to technological innovation. Taconic website,http://www.taconic.com
The company disclaims any information created by an outside party andendorses only information communicated by its press releases, filings, andwebsite. This news release contains forward-looking statements that reflectmanagement's current beliefs about the potential for its drug candidates,science, and technology. For additional information about the factors thataffect the company's business, please read the company's latest Form 10-Kfiled April 14, 2008. The company undertakes no duty to update forward-lookingstatements.
Samaritan Pharma Contact: Barrie Fuller email@example.com-- To mimic many features of human Alzheimer's including memory loss, -- Speed a scientist's "race for time" in finding a cure for the mind-robbing disease -- Save scientists valuable research money.
SOURCE Samaritan Pharmaceuticals
You May Also Like